Clinical trial
ANTIBIOTIC-RESISTANT ENTEROBACTERALES BLOODSTREAM INFECTIONS AND RISK FACTORS IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT
NCT07172932 is registered in ClinicalTrials.gov with Ankara City Hospital Bilkent as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ANTIBIOTIC-RESISTANT ENTEROBACTERALES BLOODSTREAM INFECTIONS AND RISK FACTORS IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT
- Lead sponsor
- Ankara City Hospital Bilkent
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 1, 2019
- Completion date
- January 30, 2023
- Enrollment
- 314 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antibiotic resistant infection, bloodstream infections, enterobacteriaceae infections, intensive care (icu)